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Abstract
Due to the growing need to combine data across multiple studies and to impute untyped markers
based on a reference sample, several analytical tools for imputation and analysis of missing
genotypes have been developed. Current imputation methods rely on single imputation, which
ignores the variation in estimation due to imputation. An alternative to single imputation is multiple
imputation. In this paper, we assess the variation in imputation by completing both single and
multiple imputations of genotypic data using MACH, a commonly used hidden Markov model
imputation method. Using data from the North American Rheumatoid Arthritis Consortium
g e n o m e - w i d es t u d y ,t h eu s eo fs i n g l ea n dm u l t iple imputation was assessed in four regions of
chromosome 1 with varying levels of linkage disequilibrium and association signals. Two scenarios
for missing genotypic data were assessed: imputation of untyped markers and combination of
genotypic data from two studies. This limited study involving four regions indicates that, contrary
to expectations, multiple imputations may not be necessary.
Background
Due to the growing need to combine data across
multiple studies, several analytical tools for imputation
and analysis of missing genotypes have been developed
and assessed [1-4]. These methods are particularly useful
in the context of failed genotyping and combining data
across multiple platforms, and recently have been
extended to untyped markers using a reference sample
[2-4]. Current imputation methods typically rely on
single imputation (SI); however, SI ignores the variation
in estimation due to the imputation. Therefore, one is
unable to determine the variation in association results
due to the imputation technique.
An alternative to SI is multiple imputation (MI) in which
multiple imputed or “augmented” datasets are created
and then analyzed using standard statistical methods
and models [5,6]. In this paper, we compare the use of SI
and MI using the software MACH [4] to impute genotype
“dosage” between 0 and 2. In a companion Genetic
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Open AccessAnalysis Workshop (GAW) 16 analysis, we assessed four
commonly used imputation packages (MACH [4],
fastPHASE [1], IMPUTE [2], PLINK [7]) and concluded
that using MACH or IMPUTE led to the lowest
imputation error rates [8], consistent with other reports
that MACH and IMPUTE yield similar imputation
accuracy [9,10]. We chose to use MACH rather than
IMPUTE for this comparison of SI versus MI because
MACH required less memory to run, and we considered
it to be more “user-friendly”. The comparison of SI and
MI was completed using the North American Rheuma-
toid Arthritis Consortium (NARAC) data [11]. We
examine the variation in imputation and implication
on association results.
Methods
Data
The NARAC data consists of 868 cases of rheumatoid
arthritis (RA) and 1194 controls genotyped on the 550 k
Illumina single-nucleotide polymorphism (SNP) chip
[11,12]. To mimic a variety of genetic models, we
assessed four regions on chromosome 1 (two with
positive associations, two with null associations).
Associated regions included PTPN22, which has been
reported to harbor the risk SNP rs2476601 [13,14] and
PADI4, which also has a reported risk allele for RA [15],
in which PADI4 displays lower linkage disequilibrium
(LD) than PTPN22. Two null regions on chromosome 1
were also selected: one with high LD and one with low
LD (Figure 1). Before analysis, SNPs deviating from
Hardy-Weinberg equilibrium (HWE) (p <0 . 0 0 1 )o rw i t h
call rates <95% were removed.
Single and multiple imputation
Analyses under two scenarios were completed; for both
scenarios, we have “true” genotypes. Scenario I
mimicked the situation in which completely untyped
markers were imputed. In this scenario, a set of SNPs
genotyped in the NARAC cohort were selected to be
removed based on various criteria (e.g., minor allele
frequency (MAF), significance, LD) and were then
imputed in the entire cohort. For both ‘associated’
r e g i o n s( F i g u r e1 ,Ca n d1 D ) ,t w os e t so fS N P sw e r e
imputed, resulting in a total of six datasets for analysis
(two for each associated region, one for each null
region). The risk SNP was defined as the SNP with the
strongest evidence of association (rs2476601 in PTPN22,
rs6683201 in PADI4). In the first set, the risk SNP was
imputed; in the second set, the two markers flanking the
risk SNP were imputed.
Scenario II mimicked the situation in which two studies
genotyped different set of SNPs; 1/3 of the SNPs were
genotyped only in Study I, 1/3 of the SNPs were
genotyped only in Study II, and the remaining 1/3 of
the SNPs were genotyped in both Study I and Study II.
We created the two studies by randomly splitting the
NARAC data, ensuring equal numbers of cases and
controls in each study. Likewise, the SNPs were
randomly chosen to be genotyped in Study I, Study II,
or both studies.
Each of the four regions for both scenarios were analyzed
five times using MACH version 1.0.16 [4] with phased
HapMap haplotypes for the 60 CEU founder participants
as the reference haplotypes [16]. For each region, 150
iterations were used to insure convergence, where minor
allele “dosage” (expected mean genotype) was imputed.
Syntax used for running MACH was the following:
mach1 -d region.dat -p region.ped -h region.haplos -s
region.snps –rounds 150 –greedy –geno –dosage
–quality –mask 0.02 –seed 487 > mach.out.
Associations between SNP genotypes and RA risk were
then assessed using logistic regression to estimate odds
ratios (ORs), 95% confidence intervals (CIs), and
p-values. Tests for association assumed an ordinal (log-
additive) genotypic effect on RA risk. Inference for
parameters from multiple imputations was completed
as follows: let θ represent the parameter of interest, and K
represent the number of imputed datasets (e.g., K =5 ) .
The overall point estimate of θ is the mean of the K point
estimates based on the imputed datasets. The estimated
variance of ˆ θ is defined as ˆ( ˆ)( / ) VW k B θ =+ + 11 ,w h e r e
Figure 1
Four genomic regions. (A) Null region 1 - low LD;
(B) Null region 2 - high LD; (C) Associated region - PTPN22
(D) Associated region - PADI4. SNPs in boxes indicate those
removed for imputation of completely untyped markers. For
associated regions (A and B), boxes indicate SNPs which
were imputed: blue boxes denote the set containing the
imputed risk SNP (first SNP set) and green boxes denote the
set including flanking markers to the risk SNP (second SNP
set).
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variation. Inference for θ is then based on the t-distribution
with df =( k - 1)(1 + (1/(K +1 ) ) ( W/B))
2 [5].
Results
Comparison of the standard error for the SNP coefficient
from logistic regression between SI (first run or run 1)
and MI revealed only a small differences in the standard
error and ORs between SI and MI, as illustrated with the
9 5 %C I sf o rt h eO R sf r o mS Ia n dM If o rS c e n a r i oI
(Figure 2B). The median difference in standard error
between SI and MI was -0.0004 and -0.0001 for Scenario
I and II, respectively. The median difference in ORs was
0.0005 with and IQR (interquartile range) of 0.008 for
Scenario I, while the median difference in ORs was
0.0002 with an IQR of 0.006 for Scenario II.
In terms of impact on testing for association using SI and
MI, results were very similar between SI and MI. For
Scenario I, the median difference in -log10(p-values) was
0.005 with IQR of 0.077, while for Scenario II, the
median difference was 0.002 with and IQR of 0.044.
Scenario I had slightly greater variation in p-values
b e t w e e nS Ia n dM Ia sc o m p a r e dt oS c e n a r i oI I .N e x t ,w e
evaluated the variation in imputed genotypes from two
imputation runs (run 1 and run 2), summarized by SNP
a n db ys u b j e c t ,f o rS c e n a r i oIa n dI I .T h em e d i a n
difference in imputed genotypes, summarized by SNP,
was 0.0002 (IQR = 0.002) and 0.0003 (IQR = 0.001) for
Scenario I and II, respectively. The median difference
(IQR) between imputed genotypes, when summarized
by subject, for Scenario I and II was 0.0005 (IQR =
0.011) and 0.0003 (IQR = 0.007).
LD had a greater effect on variation in imputation in
regions of low LD, as expected. For example, the
variation in imputation of genotypes from MACH was
larger in the null 1 region (low LD) as compared to the
null 2 region (high LD) (Figure 3). We also observed that
variation in ORs from association analyses completed on
multiple imputed datasets was higher in regions of low
LD (Figure 2A).
Discussion and conclusion
We have demonstrated the use of SI and MI for the
imputation of missing genotypes or untyped markers
using a reference panel. In doing so, we utilized MACH
[4], a common method that relies on LD and haplotype
estimation via a hidden Markov model. A companion
GAW16 paper assessed four commonly used imputation
packages and concluded that using MACH or IMPUTE
led to the lower imputation error rates than using
fastPHASE or PLINK [8]. Care should be taken to select
the most appropriate imputation method as well as to
determine whether to use SI or MI.
Another consideration of whether one should employ
MI is computation time. For the analyses presented,
MACH was run on a Beowolf-style Linux cluster with
compute nodes running CentOS 4.3 Linux x86-64
allowing 8-16 GB memory per job. Scenario I run-
times (single imputation) ranged from 13-18 minutes.
However, when MACH used the raw genotype data for
the reference samples instead of the phased haplotypes,
the run-time increased to more than 30 days [mach1 -d
regionPool.dat -p regionPool.ped –rounds 150 –com-
pact –geno –dosage –quality –mask 0.02 –seed 1776 >
mach.out]. In contrast, the run-times for Scenario II,
based on phased haplotypes, was around 10 minutes
Figure 2
(A) Odds ratios with 95% CI for each of the 5
imputation runs; (B) Odds ratios with 95% CI based
on SI and MI from MACH Scenario I.
Figure 3
Box plots of difference in individuals’ dosage
(observed or imputed) for each of the SNPs with
missing data (Scenario II) from MACH.
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regions.
Ignoring variation due to imputation results in under-
estimation of the variance in the parameter estimate, and
hence an inflated type I error. For imputation of untyped
markers (Scenario I), we observed larger variation in
results as compared to imputation of missing genotypes
(Scenario II). For Scenario II, we observed small
differences in association results based on SI or MI,
especially in regions of higher LD. In genome-wide
association studies in which SI is often implemented for
over two million markers, one appropriate approach is
to use SI as the initial analysis and employ MI for any
regions of interest detected with SI to assess variation
due to imputation. On the basis of this study involving
four regions, single imputation is reasonable, especially
in regions of high LD where imputed genotype “dosage”
is used in the analysis.
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